Ignite Creation Date:
2024-05-06 @ 7:38 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02575261
Status:
WITHDRAWN
Last Update Posted:
2020-07-16
First Post:
2015-09-29
Brief Title:
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
Sponsor:
Fuda Cancer Hospital Guangzhou
Organization:
Fuda Cancer Hospital Guangzhou
Organization Data
Organization:
Fuda Cancer Hospital Guangzhou
Class:
OTHER
Study ID:
CAR-T for malignant glioma
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fuda Cancer Hospital Guangzhou
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None